| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_TMEM165_0000100 | Intergenic-Exon | chr4:56262090-56278006 | chr4:55395923-55411839 | 700 nt | 0.6429 |
| hsa_TMEM165_0001700 | Exon-Exon | chr4:56269403-56278006 | chr4:55403236-55411839 | 329 nt | 0.4073 |
| hsa_TMEM165_0001800 | Exon-Exon | chr4:56269403-56284152 | chr4:55403236-55417985 | 688 nt | 0.4012 |
| hsa_TMEM165_0002900 | Exon-Exon | chr4:56277781-56278006 | chr4:55411614-55411839 | 226 nt | 0.4204 |
| hsa_TMEM165_0003000 | Exon-Exon | chr4:56277781-56284152 | chr4:55411614-55417985 | 585 nt | 0.4051 |
| hsa_TMEM165_0003100 | Intron-Exon-Intron | chr4:56277781-56284331 | chr4:55411614-55418164 | 764 nt | 0.4045 |
| hsa_TMEM165_0003200 | Exon-Exon | chr4:56277781-56290810 | chr4:55411614-55424643 | 691 nt | 0.4240 |
| hsa_TMEM165_0003300 | Exon-Intergenic | chr4:56277781-56292342 | chr4:55411614-55426175 | 1491 nt | 0.3628 |
| hsa_TMEM165_0004100 | Exon-Exon | chr4:56283239-56284152 | chr4:55417072-55417985 | 359 nt | 0.3955 |
| hsa_TMEM165_0004200 | Exon-Exon | chr4:56283239-56290810 | chr4:55417072-55424643 | 465 nt | 0.4258 |
A study in humans demonstrated that the circTMEM165 (hsa_circ_0001414) was significantly upregulated in the peripheral blood of myocardial infarction patients compared to healthy controls, as identified by RNA sequencing and validated by RT-qPCR [Li et al. DOI:10.3389/fcvm.2022.810257]. A study in human patients with ST-segment elevation myocardial infarction (STEMI) identified the circTMEM165 as a differentially expressed circular RNA in peripheral blood, a finding that was confirmed in an AC16 cell model [Wang et al. DOI:10.1515/med-2023-0807].